Rafarma Pharmaceuticals Inc. has published an amendment to their management certification for the year ending December 31, 2024. The document, originally issued on May 13, 2025, has been restated to include a required list of officers. It is important to note that this amendment was automatically generated by OTC Markets Group based on Rafarma's provided information, and OTC Markets Group disclaims any responsibility for the content of this restatement. The restated document does not specifically indicate whether the financial results themselves have been audited, and it primarily focuses on administrative updates and compliance.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.